COSMOS Pharmaceutical Corporation's market cap is currently ¥698.09B. The company's EPS TTM is ¥108.95; its P/E ratio is 22.44; and it has a dividend yield of 0.81%. COSMOS Pharmaceutical Corporation is scheduled to report earnings on July 11, 2025, and the estimated EPS forecast is ¥112.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Currency in JPY
COSMOS Pharmaceutical Corporation Earnings and Revenue History
